Binding,Release and Functionalization of Intact Pnictogen Tetrahedra Coordinated to Dicopper Complexes

The bridging MeCN ligand in the dicopper(I) complexes [(DPFN)Cu₂(μ,η¹ : η¹-MeCN)][X]₂ (X=weakly coordinating anion, NTf₂ ( 1 a ), FAl[OC₆F₁₀(C₆F₅)]₃ ( 1 b ), Al[OC(CF₃)₃]₄ ( 1 c )) was replaced by white phosphorus (P₄) or yellow arsenic (As₄) to yield [(DPFN)Cu₂(μ,η² : η²-E₄)][X]₂ (E=P ( 2 a – c ), As ( 3 a – c )). The molecular structures in the solid state reveal novel coordination modes for E₄ tetrahedra bonded to coinage metal ions. Experimental data and quantum chemical computations provide information concerning perturbations to the bonding in coordinated E₄ tetrahedra. Reactions with N-heterocyclic carbenes (NHCs) led to replacement of the E₄ tetrahedra with release of P₄ or As₄ and formation of [(DPFN)Cu₂(μ,η¹ : η¹-^MeNHC)][X]₂ ( 4 a,b ) or to an opening of one E−E bond leading to an unusual E₄ butterfly structural motif in [(DPFN)Cu₂(μ,η¹ : η¹-E₄^DippNHC)][X]₂ (E=P ( 5 a,b ), E=As ( 6 )). With a cyclic alkyl amino carbene (^EtCAAC), cleavage of two As−As bonds was observed to give two isomers of [(DPFN)Cu₂(μ,η² : η²-As₄^EtCAAC)][X]₂ ( 7 a,b ) with an unusual As₄-triangle+1 unit.     

Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs

Hydroxypyridinones (HPs) are a family of N-heterocyclic core chelators which, based on their specific metal-coordination, easy manipulation/derivatization and biocompatibility, have been an attractive target for the development of new pharmaceutical drugs with manifold uses. Herein we describe the most recent advances reported in the literature on HPs, with a special focus on the metal chelating properties of the 3-hydroxy-4-pyridinone (3,4-HP) derivatives, and the different approaches used to functionalize these chelators to improve their biological properties, namely in terms of bioavailability and specific bio-targeting abilities. Representative examples of HPs are included, mostly for applications as chelating drugs for sequestration or passivation of metal overload or deregulated biometals, but also as metallodrugs for potential diagnostic/therapeutic purposes. These examples are discussed in terms of the chelating properties and structure–activity relationships.     

Dihydroxamate based siderophore model, piperazine-1,4-bis-(N-methyl-acetohydroxamic acid (PIPDMAHA), as a chelating agent of molybdenum(VI)

Equilibrium studies based on pH-potentiometric and spectrophotometric measurements as well as some theoretical simulations are reported for the complexes of Mo(VI) with a dihydroxamate type siderophore analogue, the piperazine-1,4-bis-(N-methyl-acetohydroxamic acid) (PIPDMAHA). It has been found that the complexation process starts below pH 2 and that PIPDMAHA forms more stable O,O-hydroxamate bis-chelated complexes with Mo(VI) than any of the formerly studied dihydroxamic acids. The experimental data were fitted with two complexation models based either on dinuclear or on mononuclear species. However, ESI-MS showed that the dimmer is much more abundant than the monomer. This feature was further suggested by theoretical simulation studies, which indicated the dimeric species is more stable than the monomeric one.     

Nucleophilic displacement at benzhydryl centers: asymmetric synthesis of 1,1-diarylalkyl derivatives

[reaction: see text] Activation of substituted 1,1-diarylmethanols as their corresponding toluenesulfonates and subsequent displacement with a range of carbon, nitrogen, oxygen, and sulfur nucleophiles proceeds in 81-96% yield. Enantiomerically enriched diarylmethanols 8a-c were activated and displaced with pyridine acetate enolate with complete stereochemical inversion at carbon to yield 1,1-diarylalkyl derivatives 10a-c without loss of optical purity.     

Do‐it‐yourself functionalized silicones part 2: synthesis by ring opening polymerization of commercial cyclosiloxanes

The second paper of the series devoted to the preparation and characterization of vinyl and hydrido‐functionalized silicones proposes readily available techniques to polymerize commercially available cyclosiloxanes. This study is divided into two main sections: one relies on the synthesis of various functional silicone oils by heterogeneous cationic ring opening polymerization (ROP) of cyclotetrasiloxanes (D₄, D) and appropriate 1,3‐difunctional disiloxanes; the second part describes the anionic ROP of hexamethylcyclotrisiloxane (D₃) initiated by potassium silanolates to prepare both homo‐ and hetero‐vinyl functionalized silicones. The conditzions in which polymers with desired molecular weights can be obtained have been established and some kinetic considerations are also reported. The width of the final molar mass distribution ranged between 1.5 and 1.8, respectively, in any case narrower than the mixtures proposed by different providers (around 2). Polymers were characterized by different techniques of size exclusion chromatography (SEC), proton and silicon nuclear magnetic resonance (¹H and ²⁹Si NMR), and mass spectrometry. Copyright © 2009 John Wiley & Sons, Ltd.     

Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin,lomefloxacin and ciprofloxacin in human plasma

A simple and fast liquid chromatographic method coupled with fluorescence detection (LC‐FD) is reported, for the first time, for the simultaneous quantification of norfloxacin (NOR), ciprofloxacin (CIP) and lomefloxacin (LOM) in human plasma, using levofloxacin as internal standard (IS). Sample preparation consists of a single‐step precipitation of plasma proteins followed by vortex‐mixing and centrifugation. Chromatographic separation was achieved within 7 min on a reversed‐phase C₁₈ column with a mobile phase consisting of 0.1% aqueous formic acid (pH = 3.0, triethylamine)–methanol (82:18, v/v) pumped isocratically at 1.2 mL/min. The detector was set at excitation/emission wavelengths of 278/450 nm. Calibration curves were linear (r² ≥ 0.994) in the range of 0.02–5.0 µg/mL, and the limit of quantification was established at 0.02 µg/mL for all analytes (NOR, CIP and LOM). The overall precision did not exceed 8.19% and accuracy was within ±10.91%. NOR, CIP and LOM were extracted from human plasma with an overall mean recovery ranged from 90.1 to 111.5%. No interferences were observed at the retention times of the analytes and IS. This novel LC‐FD method enables the reliable determination of NOR, CIP and LOM in a single chromatographic run, which may be suitable to support human pharmacokinetic‐based studies with those antimicrobial agents. Copyright © 2010 John Wiley & Sons, Ltd.